Skip to content

DDN in Stroke--COBRE

Neurophysiological Characterization of Dry Needling in People With Spasticity Due to Stroke--COBRE

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05196737
Acronym
CDN
Enrollment
11
Registered
2022-01-19
Start date
2022-03-07
Completion date
2023-06-16
Last updated
2024-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CVA, Spasticity, Muscle, Stroke

Keywords

Dry Needling, Nervous System, Central Nervous System, Reflexes

Brief summary

The study team is recruiting 20 adults with spasticity due to chronic stroke for a 7 day study over 2 weeks. In people with chronic stroke, one of the most common and disabling problems is spasticity (increased muscle tone or muscle stiffness). The purpose of this research study is to examine effects of dry needling on the nervous system (pathways between the muscle, spinal cord, and brain) in people with spasticity due to chronic stroke. Dry needling is a procedure in which a thin, stainless steel needle is inserted into the skin to produce a muscle twitch response. It is intended to release a knot in the muscle and relieve pain. The total study duration is 7 visits over 2 weeks. There will be 4 visits the first week, and 3 visits the second week. The first visit will take about 1.5 hours, during which study staff will determine the best placement of electrodes and create a cast of the participant's leg to aid them in quickly placing the electrodes on the remainder of the visits. The second and fifth visits will last about 3.5 hours, and all other visits will last about 1.5 hours. Dry needling will take place on the fifth visit only. During each visit the participant will be asked to participate in examinations of reflexes (muscle responses to non-invasive nerve stimulation) and leg function.

Interventions

BEHAVIORALDry Needling

Dry needling is a procedure in which a thin, stainless steel needle is inserted into the skin to produce a muscle twitch response. It is intended to release a knot in a muscle and relieve pain.

Sponsors

National Institute of General Medical Sciences (NIGMS)
CollaboratorNIH
Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥18 years old * no known neurological injuries. * neurologically stable for \>6 months (and \>1 yr post stroke) * medical clearance to participate * unilateral ankle and/or wrist spasticity, confirmed by Modified Ashworth Scale (MAS) \> 1 and the presence of spastic hyperreflexia

Exclusion criteria

* motoneuron injury (i.e. the neurons that give rise to the axons innervating the muscles) with inadequate response to stimulation * a cardiac condition ( history of myocardial infarction, congestive heart failure, pacemaker use, coronary artery disease, atrial fibrillation, congenital heart disease, uncontrolled hypertension) * a medically unstable condition (including temporary infections and pregnancy) * age \<18 years old * cognitive impairment sufficient to interfere with informed consent or successful completion of the protocol * metal allergies * needle phobias * lymphedema over a limb (due to risk of infection/cellulitis) * abnormal bleeding tendencies * compromised immune system * vascular disease * uncontrolled diabetes * history of epilepsy (as DDN generates strong somatosensory sensation) * anxiety disorders or in distress * botox injection in target muscle within 3 months prior to start of study

Design outcomes

Primary

MeasureTime frameDescription
Ability to Move the Limb as Measured by Range of Motion (ROM)Timepoints are defined as baseline, 0-minutes post, 90 minutes post and 72 hours post DDN during intervention week and the corresponding 4 timepoints the week prior (non-intervention) but without DDN.ROM is measured in degrees using a standard goniometer. ROM will be measured both passively (moved by the assessor) and actively (participant moves the leg themselves) and the value reported is the maximum degree of dorsiflexion in each condition. Positive values indicate degrees of dorsiflexion beyond neutral, negative values indicate degrees of plantarflexion. Greater values indicate greater degrees of dorsiflexion.
Changes in the H-reflex Amplitude in Response to Nerve Stimulation7 days prior (2 time points), 6 days prior, 4 days prior, baseline, immediately after DDN, 90 minutes after DDN, 24 hours after DDN, and 72 hours after DDNH-reflex amplitude (mV) reflects the excitability of its reflex pathway. Changes in the H-reflex amplitude indicate that DDN influences the spinal excitability. This will be measured in the tibialis anterior and the triceps surae.
Changes in Cutaneous Reflexes Elicited by Non-noxious Stimulation of Cutaneous or Mix Nerves7 days prior (2 time points), 6 days prior, 4 days prior, baseline, immediately after DDN, 90 minutes after DDN, 24 hours after DDN, and 72 hours after DDNChanges in the cutaneous reflex amplitudes would indicate that DDN can influence the spinal processing of cutaneous information.
Changes in Perception of Cutaneous Stimuli as Measured by Perception and Radiating Threshold of Cutaneous Nerve Stimulation7 days prior (2 time points), 6 days prior, 4 days prior, baseline, immediately after DDN, 90 minutes after DDN, 24 hours after DDN, and 72 hours after DDNChanges in the cutaneous reflex amplitudes would indicate that DDN can influence the spinal processing of cutaneous information.

Secondary

MeasureTime frameDescription
Ability to Move the Leg as Measured by the Fugl-Meyer Assessment (FMA) Lower ExtremityTimepoints are defined as baseline, 0-minutes post, 90 minutes post and 72 hours post DDN during intervention week and the corresponding 4 timepoints the week prior (non-intervention) but without DDN.An increase in the FMA-LE score indicates better movement of the leg. Score ranges from 0 - 34.
Change in Spasticity as Measured by the Modified Ashworth Scale (mAS)baseline, immediately after DDN, 90 minutes after DDN, 24 hours after, and 72 hours after DDNThe mAS score ranges from 0: normal muscle tone to 4: rigid in flexion or extension. A decrease in mAS indicates decreased spasticity. A score of 1.5 reported below is equal to 1+ on the mAS
Change in Pain Level as Measured by the Visual Analog Scale (VAS) for Pain7 days prior (2 time points), 6 days prior, 4 days prior, baseline, immediately after DDN, 90 minutes after DDN, 24 hours after DDN, and 72 hours after DDNPain is rated by the participant on a scale from 0 (no pain) to 10 (worst pain imaginable). Decreased score on the VAS for pain indicates decreased pain.
Change in Time Needed to Walk 10 Meter (10 m Walk Test)Timepoints are defined as baseline, 0-minutes post, 24 hours post and 72 hours post DDN during intervention week and the corresponding 4 timepoints the week prior (non-intervention) but without DDN.Decreased time indicates improved ability to walk

Countries

United States

Participant flow

Pre-assignment details

Participants were enrolled in a cross-sectional study. Eleven participants were enrolled in the non-intervention week, of which 9 participants completed all visits. Those 9 participants went on to the Dry Needling Reflex Measurements, of which 8 participants completed all visits. So 11 participants were enrolled, and 8 completed the study procedures.

Participants by arm

ArmCount
Single Arm
Baseline reflex measurements will be collected during the first week of the study (Visits 1-4). No dry needling will occur during this week. The aim of this arm is to track any natural variability in nervous system excitability at the same time points as reflex measurements during the intervention week. All participants who participated in baseline reflex measurements during week 1 will continue to the second week of the study (Visits 5-7). Participants will receive dry needling to relieve spasticity in the target calf muscle (middle gastrocnemius) during Visit 5. The study team will examine the effects of this treatment on the nervous system by performing assessments just prior to DDN, immediately after DDN, 90 minutes after DDN, 24 hours after DDN, and 72 hours after DDN. These assessments will examine how you move your leg and how your nervous system responds to non-invasive nerve stimulation. Dry Needling: Dry needling is a procedure in which a thin, stainless steel needle is inserted into the skin to produce a muscle twitch response. It is intended to release a knot in a muscle and relieve pain.
11
Total11

Withdrawals & dropouts

PeriodReasonFG000
Dry Needling Reflex Measurment WeekProtocol Violation1
Non-intervention WeekLost to Follow-up2

Baseline characteristics

CharacteristicSingle Arm
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
11 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
11 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
4 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
5 Participants
Region of Enrollment
United States
11 Participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 110 / 11
other
Total, other adverse events
0 / 110 / 11
serious
Total, serious adverse events
0 / 110 / 11

Outcome results

Primary

Ability to Move the Limb as Measured by Range of Motion (ROM)

ROM is measured in degrees using a standard goniometer. ROM will be measured both passively (moved by the assessor) and actively (participant moves the leg themselves) and the value reported is the maximum degree of dorsiflexion in each condition. Positive values indicate degrees of dorsiflexion beyond neutral, negative values indicate degrees of plantarflexion. Greater values indicate greater degrees of dorsiflexion.

Time frame: Timepoints are defined as baseline, 0-minutes post, 90 minutes post and 72 hours post DDN during intervention week and the corresponding 4 timepoints the week prior (non-intervention) but without DDN.

ArmMeasureGroupValue (MEDIAN)Dispersion
Single ArmAbility to Move the Limb as Measured by Range of Motion (ROM)passive DF ROM (with knee extended) 90-min post0 maximum degrees of dorsiflexionStandard Deviation 5.26
Single ArmAbility to Move the Limb as Measured by Range of Motion (ROM)passive DF ROM (with knee flexed) post-0 min DDN4 maximum degrees of dorsiflexionStandard Deviation 8.3
Single ArmAbility to Move the Limb as Measured by Range of Motion (ROM)active DF ROM (with knee extended) 0-min post-26 maximum degrees of dorsiflexionStandard Deviation 11.36
Single ArmAbility to Move the Limb as Measured by Range of Motion (ROM)passive DF ROM (with knee flexed) post-90 min DDN2.5 maximum degrees of dorsiflexionStandard Deviation 6.57
Single ArmAbility to Move the Limb as Measured by Range of Motion (ROM)passive DF ROM (with knee extended) 0-min post0 maximum degrees of dorsiflexionStandard Deviation 4.62
Single ArmAbility to Move the Limb as Measured by Range of Motion (ROM)passive DF ROM post-72 hr DDN4.5 maximum degrees of dorsiflexionStandard Deviation 4.64
Single ArmAbility to Move the Limb as Measured by Range of Motion (ROM)active DF ROM (with knee extended) 90-min post-26.5 maximum degrees of dorsiflexionStandard Deviation 9.34
Single ArmAbility to Move the Limb as Measured by Range of Motion (ROM)active DF ROM (with knee flexed) baseline-24.5 maximum degrees of dorsiflexionStandard Deviation 13.8
Single ArmAbility to Move the Limb as Measured by Range of Motion (ROM)passive DF ROM (with knee extended) 72 hour post0 maximum degrees of dorsiflexionStandard Deviation 6.2
Single ArmAbility to Move the Limb as Measured by Range of Motion (ROM)active DF ROM (with knee flexed) post-0 min DDN-20 maximum degrees of dorsiflexionStandard Deviation 8.29
Single ArmAbility to Move the Limb as Measured by Range of Motion (ROM)active DF ROM (with knee extended) 72-hr post-22 maximum degrees of dorsiflexionStandard Deviation 11.51
Single ArmAbility to Move the Limb as Measured by Range of Motion (ROM)active DF ROM (with knee flexed) post-90 min DDN-19 maximum degrees of dorsiflexionStandard Deviation 6.85
Single ArmAbility to Move the Limb as Measured by Range of Motion (ROM)active DF ROM (with knee extended) baseline-28.5 maximum degrees of dorsiflexionStandard Deviation 10.92
Single ArmAbility to Move the Limb as Measured by Range of Motion (ROM)active DF ROM (with knee flexed) post-72 hr DDN-17 maximum degrees of dorsiflexionStandard Deviation 10.92
Single ArmAbility to Move the Limb as Measured by Range of Motion (ROM)passive DF ROM (with knee flexed) baseline2.5 maximum degrees of dorsiflexionStandard Deviation 6
Single ArmAbility to Move the Limb as Measured by Range of Motion (ROM)passive DF ROM (with knee extended) baseline0.5 maximum degrees of dorsiflexionStandard Deviation 4.09
Dry Needling Reflex MeasurementsAbility to Move the Limb as Measured by Range of Motion (ROM)passive DF ROM (with knee extended) 72 hour post0 maximum degrees of dorsiflexionStandard Deviation 11.51
Dry Needling Reflex MeasurementsAbility to Move the Limb as Measured by Range of Motion (ROM)passive DF ROM (with knee extended) baseline0 maximum degrees of dorsiflexionStandard Deviation 3.89
Dry Needling Reflex MeasurementsAbility to Move the Limb as Measured by Range of Motion (ROM)passive DF ROM (with knee extended) 0-min post0.5 maximum degrees of dorsiflexionStandard Deviation 3.83
Dry Needling Reflex MeasurementsAbility to Move the Limb as Measured by Range of Motion (ROM)passive DF ROM (with knee extended) 90-min post3 maximum degrees of dorsiflexionStandard Deviation 3.93
Dry Needling Reflex MeasurementsAbility to Move the Limb as Measured by Range of Motion (ROM)active DF ROM (with knee extended) baseline-24.5 maximum degrees of dorsiflexionStandard Deviation 8.94
Dry Needling Reflex MeasurementsAbility to Move the Limb as Measured by Range of Motion (ROM)active DF ROM (with knee extended) 0-min post-22.5 maximum degrees of dorsiflexionStandard Deviation 7.14
Dry Needling Reflex MeasurementsAbility to Move the Limb as Measured by Range of Motion (ROM)active DF ROM (with knee extended) 90-min post-22 maximum degrees of dorsiflexionStandard Deviation 9.24
Dry Needling Reflex MeasurementsAbility to Move the Limb as Measured by Range of Motion (ROM)active DF ROM (with knee extended) 72-hr post-21 maximum degrees of dorsiflexionStandard Deviation 12.06
Dry Needling Reflex MeasurementsAbility to Move the Limb as Measured by Range of Motion (ROM)passive DF ROM (with knee flexed) baseline5.5 maximum degrees of dorsiflexionStandard Deviation 5.66
Dry Needling Reflex MeasurementsAbility to Move the Limb as Measured by Range of Motion (ROM)passive DF ROM (with knee flexed) post-0 min DDN8 maximum degrees of dorsiflexionStandard Deviation 3.7
Dry Needling Reflex MeasurementsAbility to Move the Limb as Measured by Range of Motion (ROM)passive DF ROM (with knee flexed) post-90 min DDN8 maximum degrees of dorsiflexionStandard Deviation 4.93
Dry Needling Reflex MeasurementsAbility to Move the Limb as Measured by Range of Motion (ROM)passive DF ROM post-72 hr DDN5.5 maximum degrees of dorsiflexionStandard Deviation 5.28
Dry Needling Reflex MeasurementsAbility to Move the Limb as Measured by Range of Motion (ROM)active DF ROM (with knee flexed) baseline-14 maximum degrees of dorsiflexionStandard Deviation 12.71
Dry Needling Reflex MeasurementsAbility to Move the Limb as Measured by Range of Motion (ROM)active DF ROM (with knee flexed) post-0 min DDN-16 maximum degrees of dorsiflexionStandard Deviation 10.23
Dry Needling Reflex MeasurementsAbility to Move the Limb as Measured by Range of Motion (ROM)active DF ROM (with knee flexed) post-90 min DDN-15.5 maximum degrees of dorsiflexionStandard Deviation 9.52
Dry Needling Reflex MeasurementsAbility to Move the Limb as Measured by Range of Motion (ROM)active DF ROM (with knee flexed) post-72 hr DDN-15.5 maximum degrees of dorsiflexionStandard Deviation 13.15
Primary

Changes in Cutaneous Reflexes Elicited by Non-noxious Stimulation of Cutaneous or Mix Nerves

Changes in the cutaneous reflex amplitudes would indicate that DDN can influence the spinal processing of cutaneous information.

Time frame: 7 days prior (2 time points), 6 days prior, 4 days prior, baseline, immediately after DDN, 90 minutes after DDN, 24 hours after DDN, and 72 hours after DDN

Population: Due to equipment malfunction, we could not obtain data with adequate quality for this analysis.

Primary

Changes in Perception of Cutaneous Stimuli as Measured by Perception and Radiating Threshold of Cutaneous Nerve Stimulation

Changes in the cutaneous reflex amplitudes would indicate that DDN can influence the spinal processing of cutaneous information.

Time frame: 7 days prior (2 time points), 6 days prior, 4 days prior, baseline, immediately after DDN, 90 minutes after DDN, 24 hours after DDN, and 72 hours after DDN

Population: Due to equipment malfunction, we could not obtain data with adequate quality for this analysis.

Primary

Changes in the H-reflex Amplitude in Response to Nerve Stimulation

H-reflex amplitude (mV) reflects the excitability of its reflex pathway. Changes in the H-reflex amplitude indicate that DDN influences the spinal excitability. This will be measured in the tibialis anterior and the triceps surae.

Time frame: 7 days prior (2 time points), 6 days prior, 4 days prior, baseline, immediately after DDN, 90 minutes after DDN, 24 hours after DDN, and 72 hours after DDN

Population: Due to equipment malfunction, we could not obtain data with adequate quality for this analysis.

Secondary

Ability to Move the Leg as Measured by the Fugl-Meyer Assessment (FMA) Lower Extremity

An increase in the FMA-LE score indicates better movement of the leg. Score ranges from 0 - 34.

Time frame: Timepoints are defined as baseline, 0-minutes post, 90 minutes post and 72 hours post DDN during intervention week and the corresponding 4 timepoints the week prior (non-intervention) but without DDN.

ArmMeasureGroupValue (MEDIAN)Dispersion
Single ArmAbility to Move the Leg as Measured by the Fugl-Meyer Assessment (FMA) Lower ExtremityMedian FMA-LE score baseline22 score on a scaleStandard Deviation 5
Single ArmAbility to Move the Leg as Measured by the Fugl-Meyer Assessment (FMA) Lower ExtremityMedian FMA-LE score 0-min post24 score on a scaleStandard Deviation 5.01
Single ArmAbility to Move the Leg as Measured by the Fugl-Meyer Assessment (FMA) Lower ExtremityMedian FMA-LE score 90 min post22.5 score on a scaleStandard Deviation 5.68
Single ArmAbility to Move the Leg as Measured by the Fugl-Meyer Assessment (FMA) Lower ExtremityMedian FMA-LE score 72 hr post22.5 score on a scaleStandard Deviation 5.44
Dry Needling Reflex MeasurementsAbility to Move the Leg as Measured by the Fugl-Meyer Assessment (FMA) Lower ExtremityMedian FMA-LE score 72 hr post21 score on a scaleStandard Deviation 4.97
Dry Needling Reflex MeasurementsAbility to Move the Leg as Measured by the Fugl-Meyer Assessment (FMA) Lower ExtremityMedian FMA-LE score baseline20 score on a scaleStandard Deviation 5.23
Dry Needling Reflex MeasurementsAbility to Move the Leg as Measured by the Fugl-Meyer Assessment (FMA) Lower ExtremityMedian FMA-LE score 90 min post21 score on a scaleStandard Deviation 4.78
Dry Needling Reflex MeasurementsAbility to Move the Leg as Measured by the Fugl-Meyer Assessment (FMA) Lower ExtremityMedian FMA-LE score 0-min post19.5 score on a scaleStandard Deviation 5.19
Secondary

Change in Pain Level as Measured by the Visual Analog Scale (VAS) for Pain

Pain is rated by the participant on a scale from 0 (no pain) to 10 (worst pain imaginable). Decreased score on the VAS for pain indicates decreased pain.

Time frame: 7 days prior (2 time points), 6 days prior, 4 days prior, baseline, immediately after DDN, 90 minutes after DDN, 24 hours after DDN, and 72 hours after DDN

Population: No pain was reported by any participant throughout the study. All participants reported 0 pain at all time points.

ArmMeasureValue (MEAN)Dispersion
Single ArmChange in Pain Level as Measured by the Visual Analog Scale (VAS) for Pain0 score on a scaleStandard Deviation 0
Secondary

Change in Spasticity as Measured by the Modified Ashworth Scale (mAS)

The mAS score ranges from 0: normal muscle tone to 4: rigid in flexion or extension. A decrease in mAS indicates decreased spasticity. A score of 1.5 reported below is equal to 1+ on the mAS

Time frame: baseline, immediately after DDN, 90 minutes after DDN, 24 hours after, and 72 hours after DDN

ArmMeasureGroupValue (NUMBER)
Single ArmChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 13 score on a scale
Single ArmChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 141.5 score on a scale
Single ArmChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 83 score on a scale
Single ArmChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 42 score on a scale
Single ArmChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 23 score on a scale
Single ArmChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 52 score on a scale
Single ArmChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 63 score on a scale
Dry Needling Reflex MeasurementsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 63 score on a scale
Dry Needling Reflex MeasurementsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 52 score on a scale
Dry Needling Reflex MeasurementsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 22 score on a scale
Dry Needling Reflex MeasurementsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 13 score on a scale
Dry Needling Reflex MeasurementsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 83 score on a scale
Dry Needling Reflex MeasurementsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 41.5 score on a scale
Dry Needling Reflex MeasurementsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 141.5 score on a scale
Post-90 MinChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 52 score on a scale
Post-90 MinChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 13 score on a scale
Post-90 MinChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 22 score on a scale
Post-90 MinChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 41.5 score on a scale
Post-90 MinChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 63 score on a scale
Post-90 MinChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 83 score on a scale
Post-90 MinChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 141.5 score on a scale
Post-24 HrsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 42 score on a scale
Post-24 HrsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 63 score on a scale
Post-24 HrsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 22 score on a scale
Post-24 HrsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 141 score on a scale
Post-24 HrsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 83 score on a scale
Post-24 HrsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 13 score on a scale
Post-24 HrsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 52 score on a scale
Post-72 HrsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 42 score on a scale
Post-72 HrsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 141 score on a scale
Post-72 HrsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 83 score on a scale
Post-72 HrsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 63 score on a scale
Post-72 HrsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 23 score on a scale
Post-72 HrsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 13 score on a scale
Post-72 HrsChange in Spasticity as Measured by the Modified Ashworth Scale (mAS)Participant 53 score on a scale
Secondary

Change in Time Needed to Walk 10 Meter (10 m Walk Test)

Decreased time indicates improved ability to walk

Time frame: Timepoints are defined as baseline, 0-minutes post, 24 hours post and 72 hours post DDN during intervention week and the corresponding 4 timepoints the week prior (non-intervention) but without DDN.

ArmMeasureGroupValue (MEDIAN)Dispersion
Single ArmChange in Time Needed to Walk 10 Meter (10 m Walk Test)Median 10MWT time in seconds 24 hours post8.175 secondsStandard Deviation 1.99
Single ArmChange in Time Needed to Walk 10 Meter (10 m Walk Test)Median 10MWT time in seconds 72 hours post7.945 secondsStandard Deviation 1.9
Single ArmChange in Time Needed to Walk 10 Meter (10 m Walk Test)Median 10MWT time in seconds 90 min post9.515 secondsStandard Deviation 2.52
Single ArmChange in Time Needed to Walk 10 Meter (10 m Walk Test)Median 10MWT time in seconds at baseline9.525 secondsStandard Deviation 2.61
Dry Needling Reflex MeasurementsChange in Time Needed to Walk 10 Meter (10 m Walk Test)Median 10MWT time in seconds 90 min post8.1 secondsStandard Deviation 2
Dry Needling Reflex MeasurementsChange in Time Needed to Walk 10 Meter (10 m Walk Test)Median 10MWT time in seconds 24 hours post7.57 secondsStandard Deviation 2.44
Dry Needling Reflex MeasurementsChange in Time Needed to Walk 10 Meter (10 m Walk Test)Median 10MWT time in seconds 72 hours post7.555 secondsStandard Deviation 2.13
Dry Needling Reflex MeasurementsChange in Time Needed to Walk 10 Meter (10 m Walk Test)Median 10MWT time in seconds at baseline7.91 secondsStandard Deviation 2.25

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026